l‐asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein–Barr virus infection.

MLA

Furukawa, Yoshiki, et al. “L‐asparaginase Monotherapy as an Encouraging Approach towards Acute Fulminant Chronic Active Epstein–Barr Virus Infection.” British Journal of Haematology, vol. 205, no. 4, Oct. 2024, pp. 1610–14. EBSCOhost, https://doi.org/10.1111/bjh.19652.

APA

Furukawa, Y., Ando, J., Ishii, M., Kinoshita, S., Goto, A., Tachibana, K., Azusawa, Y., Kato, T., Izumi, N., Hosoya, E., Uchimura, A., Inano, T., Shirane, S., Tsukune, Y., Takaku, T., Hamano, Y., & Ando, M. (2024). l‐asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein–Barr virus infection. British Journal of Haematology, 205(4), 1610–1614. https://doi.org/10.1111/bjh.19652

Chicago

Furukawa, Yoshiki, Jun Ando, Midori Ishii, Shintaro Kinoshita, Ayaka Goto, Kota Tachibana, Yoko Azusawa, et al. 2024. “L‐asparaginase Monotherapy as an Encouraging Approach towards Acute Fulminant Chronic Active Epstein–Barr Virus Infection.” British Journal of Haematology 205 (4): 1610–14. doi:10.1111/bjh.19652.